Skip to main content
Clinical Trials/NCT03211338
NCT03211338CompletedNot Applicable

Inflammation and Cell Maturation in Preterm Delivery Placentas - in Vitro and in Vivo Effect of Progesterone

Hillel Yaffe Medical Center1 site in 1 country115 target enrollmentStarted: July 15, 2017Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
115
Locations
1
Primary Endpoint
Maturation effects of progesterone on preterm and term placentas

Study Overview

Brief Summary

The aim of this study is to investigate the In Vitro and In Vivo effect of progesterone on immature myeloid cells (IMC), inflammation characteristics and maturation into dendritic cells (DC).

Study Design

Study Type
Interventional
Allocation
Non Randomized
Intervention Model
Parallel
Primary Purpose
Basic Science
Masking
None

Eligibility Criteria

Ages
18 Years to 40 Years (Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Placentas from term and preterm deliveries
  • •Singleton pregnancy
  • •Consent to participate

Exclusion Criteria

  • •Pregnancies with obstetric complications
  • •Multiple gestation
  • •Maternal illness or fetal malformation known pre-delivery

Arms & Interventions

Preterm labor placentas and progesterone

Active Comparator

IMC cells taken from preterm labor placentas after delivery will be cultured with progesterone and will be analyzed for inflammation characteristics and maturation into DC cells.

Intervention: Culture with progesterone (Biological)

Term labor placentas and progesterone

Active Comparator

IMC cells taken from term labor placentas after delivery will be cultured with progesterone and will be analyzed for inflammation characteristics and maturation into DC cells.

Intervention: Culture with progesterone (Biological)

Preterm labor placentas without progesterone

Active Comparator

IMC cells taken from preterm labor placentas after delivery will be cultured without progesterone and will be analyzed for inflammation characteristics and maturation into DC cells.

Intervention: Culture without progesterone (Biological)

Term labor placentas without progesterone

Active Comparator

IMC cells taken from term labor placentas after delivery will be cultured without progesterone and will be analyzed for inflammation characteristics and maturation into DC cells.

Intervention: Culture without progesterone (Biological)

Term placentas from progesterone treated pregnancies

Active Comparator

IMC cells taken from term labor placentas from women that were treated with progesterone during pregnancy will be analyzed for inflammation characteristics and maturation into DC cells.

Intervention: Culture with growth factors (Biological)

Preterm placentas from progesterone treated pregnancies

Active Comparator

IMC cells taken from preterm labor placentas from women that were treated with progesterone during pregnancy will be analyzed for inflammation characteristics and maturation into DC cells.

Intervention: Culture with growth factors (Biological)

Term placentas not treated with progesterone in pregnancy

Active Comparator

IMC cells taken from term placentas from women who were not treated with progesterone during pregnancy will be analyzed for inflammation characteristics and maturation into DC cells.

Intervention: Culture with growth factors (Biological)

Preterm placentas not treated with progesterone in pregnancy

Active Comparator

IMC cells taken from preterm placentas from women who were not treated with progesterone during pregnancy will be analyzed for inflammation characteristics and maturation into DC cells.

Intervention: Culture with growth factors (Biological)

Term postpartum blood samples with progesterone

Active Comparator

CD-14+ monocyte cells taken from women delivering at term will be cultured with progesterone and will be analyzed for inflammation characteristics and maturation into DC cells.

Intervention: Culture with progesterone (Biological)

Preterm postpartum blood samples with progesterone

Active Comparator

CD-14+ monocyte cells taken from women delivering preterm will be cultured with progesterone and will be analyzed for inflammation characteristics and maturation into DC cells.

Intervention: Culture with progesterone (Biological)

Term postpartum blood samples without progesterone

Active Comparator

CD-14+ monocyte cells taken from women delivering at term will be cultured without progesterone and will be analyzed for inflammation characteristics and maturation into DC cells.

Intervention: Culture without progesterone (Biological)

Preterm postpartum blood samples without progesterone

Active Comparator

CD-14+ monocyte cells taken from women delivering preterm will be cultured without progesterone and will be analyzed for inflammation characteristics and maturation into DC cells.

Intervention: Culture without progesterone (Biological)

Outcomes

Primary Outcomes

Maturation effects of progesterone on preterm and term placentas

Time Frame: One year

Differences observed in maturation of IMC cells into DC cells in term and preterm placentas

Inflammation characteristic effects of progesterone on preterm and term placentas

Time Frame: One year

Differences observed in cytokine profiles of IMC cells from term and preterm placentas cultured with and without progesterone

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other Gov
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials